These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38807690)

  • 1. Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.
    Yu Z; Burback L; Winkler O; Xu L; Dennett L; Vermetten E; Greenshaw A; Li XM; Milne M; Wang F; Cao B; Winship IR; Zhang Y; Chan AW
    Front Psychiatry; 2024; 15():1386321. PubMed ID: 38807690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.
    Kuburi S; Di Passa AM; Tassone VK; Mahmood R; Lalovic A; Ladha KS; Dunlop K; Rizvi S; Demchenko I; Bhat V
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221115342. PubMed ID: 35936944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Default Mode Network Modulation by Psychedelics: A Systematic Review.
    Gattuso JJ; Perkins D; Ruffell S; Lawrence AJ; Hoyer D; Jacobson LH; Timmermann C; Castle D; Rossell SL; Downey LA; Pagni BA; Galvão-Coelho NL; Nutt D; Sarris J
    Int J Neuropsychopharmacol; 2023 Mar; 26(3):155-188. PubMed ID: 36272145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.
    Avram M; Müller F; Rogg H; Korda A; Andreou C; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Sep; 7(9):885-894. PubMed ID: 35500840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
    Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
    Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.
    Breeksema JJ; Kuin BW; Kamphuis J; van den Brink W; Vermetten E; Schoevers RA
    J Psychopharmacol; 2022 Oct; 36(10):1100-1117. PubMed ID: 36017784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.
    Pasquini L; Palhano-Fontes F; Araujo DB
    J Psychopharmacol; 2020 Jun; 34(6):623-635. PubMed ID: 32255395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.
    Hovmand OR; Poulsen ED; Arnfred S
    J Psychopharmacol; 2024 Jan; 38(1):19-32. PubMed ID: 37969069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.
    Yao Y; Guo D; Lu TS; Liu FL; Huang SH; Diao MQ; Li SX; Zhang XJ; Kosten TR; Shi J; Bao YP; Lu L; Han Y
    Psychiatry Res; 2024 May; 335():115886. PubMed ID: 38574699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.
    Gaddis A; Lidstone DE; Nebel MB; Griffiths RR; Mostofsky SH; Mejia AF; Barrett FS
    Neuroimage; 2022 Oct; 260():119434. PubMed ID: 35792293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D; Barrett FS; Vandrey R
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.
    Weleff J; Akiki TJ; Barnett BS
    J Psychoactive Drugs; 2023; 55(4):434-444. PubMed ID: 36218281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.
    Palhano-Fontes F; Andrade KC; Tofoli LF; Santos AC; Crippa JA; Hallak JE; Ribeiro S; de Araujo DB
    PLoS One; 2015; 10(2):e0118143. PubMed ID: 25693169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.
    Smigielski L; Scheidegger M; Kometer M; Vollenweider FX
    Neuroimage; 2019 Aug; 196():207-215. PubMed ID: 30965131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.
    Cruzat J; Perl YS; Escrichs A; Vohryzek J; Timmermann C; Roseman L; Luppi AI; Ibañez A; Nutt D; Carhart-Harris R; Tagliazucchi E; Deco G; Kringelbach ML
    Netw Neurosci; 2022; 6(4):1104-1124. PubMed ID: 38800462
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.